Mesirow Institutional Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$18.5M Sell
224,266
-765
-0.3% -$60.3K 1.43% 12
2024
Q3
$16.1M Sell
225,031
-34,450
-13% -$2.43M 1.23% 23
2024
Q2
$17.8M Sell
259,481
-28,560
-10% -$1.71M 1.56% 3
2024
Q1
$15.5M Sell
288,041
-197
-0.1% -$10.6K 1.37% 17
2023
Q4
$15.4M Buy
288,238
+226,133
+364% +$11M 1.44% 18
2023
Q3
$3.08M Buy
62,105
+23,200
+60% +$1.3M 0.31% 85
2023
Q2
$2.32M Buy
38,905
+7,530
+24% +$429K 0.24% 100
2023
Q1
$1.78M Buy
+31,375
New +$2.01M 0.19% 134

Other funds holding GMED

Mesirow Institutional Investment Management's GMED Position: Q4 2024 in Review

Mesirow Institutional Investment Management reduced its Globus Medical (GMED) stake by 0.34% in Q4 2024, selling an estimated $60.3K and leaving 224,266 shares worth $18.5M. The position accounts for 1.43% of the portfolio, ranked #12.

Mesirow Institutional Investment Management first reported a position in GMED in Q1 2023 and has held it in 8 quarters since. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • Mesirow Institutional Investment Management held 224,266 shares of Globus Medical worth $18.5M as of Q4 2024.
  • Mesirow Institutional Investment Management sold 765 Globus Medical shares in Q4 2024, an estimated $60.3K.
  • Globus Medical made up 1.43% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #12 holding.
  • Mesirow Institutional Investment Management first reported a position in Globus Medical in Q1 2023 and has held it in 8 quarters since.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.